Clinical Chemistry: A Glimpse into the Future

Abstract

After 18 years of distinguished service, Dr. David Bruns has retired from his post as the editor in chief of Clinical Chemistry . During his tenure, the journal was transformed into the world’s leading publication in laboratory medicine, with the highest impact factor and citation index. Over the years, Clinical Chemistry has evolved to reflect changes in the field by publishing articles addressing not only traditional clinical chemistry but also emerging areas such as molecular diagnostics, evidence-based medicine, and proteomics. I am honored to have been given the opportunity, as the new editor in chief, to continue the fine tradition established by those who have previously led this journal. In this new role, my first crucial task was to assemble the best editorial team possible. I am delighted that Drs. James Boyd and Thomas Annesley have agreed to serve as deputy editors. They both bring a wealth of knowledge and experience to the journal, with which they have had a long association and are intimately familiar. In addition to assisting me in conducting the usual editorial duties, the deputies will act as close advisors to help implement my vision for the journal and to strive to enhance its scientific and educational values. The journal cannot exist without the contributions of the associate editors, who work tirelessly to determine which articles, in their respective areas of expertise, …